SEC 13F Intelligence

Natixis Advisors, LLC / BSX

Natixis Advisors, LLC’s Boston Scientific Corp Position

Does Natixis Advisors, LLC own Boston Scientific Corp (BSX)? Yes — 1.87M shares worth $117M (+0.16% of its 13F portfolio) as of Q1 2026, down from 2.21M shares the prior filed quarter.

Position Value
$117M
Q1 2026
Shares
1.87M
% of Portfolio
+0.16%
Quarters Held
30
currently held

Position History BSX

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $5MQ2 ’19: $6MQ3 ’19: $7MQ4 ’19: $9MQ4 ’19Q1 ’20: $13MQ2 ’20: $16MQ3 ’20: $19MQ4 ’20: $19MQ4 ’20Q1 ’21: $22MQ2 ’21: $26MQ3 ’21: $25MQ4 ’21: $25MQ4 ’21Q1 ’22: $29MQ2 ’22: $22MQ3 ’22: $33MQ4 ’22: $48MQ4 ’22Q1 ’23: $52MQ2 ’23: $47MQ3 ’23: $94MQ4 ’23: $99MQ4 ’23Q1 ’24: $115MQ2 ’24: $135MQ3 ’24: $155MQ4 ’24: $181MQ4 ’24Q1 ’25: $219MQ2 ’25: $269MQ3 ’25: $245MQ4 ’25: $211MQ4 ’25Q1 ’26: $117Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.87M$117M+0.16%
Q4 20252.21M$211M+0.30%
Q3 20252.51M$245M+0.36%
Q2 20252.50M$269M+0.43%
Q1 20252.17M$219M+0.40%
Q4 20242.03M$181M+0.34%
Q3 20241.85M$155M+0.30%
Q2 20241.75M$135M+0.29%
Q1 20241.69M$115M+0.27%
Q4 20231.72M$99M+0.26%
Q3 20231.78M$94M+0.29%
Q2 2023873.0K$47M+0.15%
Q1 20231.03M$52M+0.18%
Q4 20221.03M$48M+0.18%
Q3 2022853.1K$33M+0.14%
Q2 2022583.7K$22M+0.10%
Q1 2022644.4K$29M+0.11%
Q4 2021594.9K$25M+0.10%
Q3 2021581.6K$25M+0.10%
Q2 2021603.5K$26M+0.12%
Q1 2021578.9K$22M+0.12%
Q4 2020534.3K$19M+0.11%
Q3 2020486.3K$19M+0.12%
Q2 2020461.2K$16M+0.11%
Q1 2020385.1K$13M+0.10%
Q4 2019198.0K$9M+0.06%
Q3 2019180.7K$7M+0.06%
Q2 2019141.8K$6M+0.05%
Q1 2019130.3K$5M+0.04%
Q4 2018137.0K$5M+0.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of BSX.